IT8522493A0 - Ottenute. procedimento per la preparazione di compresse, anche a rilascio prolungato, di isosorbide-5-mononitrato stabilizzato e formulazioni cosi' - Google Patents

Ottenute. procedimento per la preparazione di compresse, anche a rilascio prolungato, di isosorbide-5-mononitrato stabilizzato e formulazioni cosi'

Info

Publication number
IT8522493A0
IT8522493A0 IT8522493A IT2249385A IT8522493A0 IT 8522493 A0 IT8522493 A0 IT 8522493A0 IT 8522493 A IT8522493 A IT 8522493A IT 2249385 A IT2249385 A IT 2249385A IT 8522493 A0 IT8522493 A0 IT 8522493A0
Authority
IT
Italy
Prior art keywords
mononitrate
isosorbide
tablets
formulations
stabilized
Prior art date
Application number
IT8522493A
Other languages
English (en)
Other versions
IT1187750B (it
Inventor
Piergiorgio Rossi
Massimo Calanchi
Original Assignee
Eurand Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Spa filed Critical Eurand Spa
Publication of IT8522493A0 publication Critical patent/IT8522493A0/it
Priority to IT22493/85A priority Critical patent/IT1187750B/it
Priority to DE8686201705T priority patent/DE3683342D1/de
Priority to ES198686201705T priority patent/ES2035819T3/es
Priority to EP86201705A priority patent/EP0219161B1/en
Priority to AT86201705T priority patent/ATE71290T1/de
Priority to JP61241570A priority patent/JPS62123114A/ja
Priority to AU63831/86A priority patent/AU591185B2/en
Priority to US06/918,385 priority patent/US4812316A/en
Priority to ZA867768A priority patent/ZA867768B/xx
Priority to CA000520377A priority patent/CA1285489C/en
Application granted granted Critical
Publication of IT1187750B publication Critical patent/IT1187750B/it
Priority to GR920400639T priority patent/GR3004285T3/el
Priority to HK12295A priority patent/HK12295A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT22493/85A 1985-10-15 1985-10-15 Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute IT1187750B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT22493/85A IT1187750B (it) 1985-10-15 1985-10-15 Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute
DE8686201705T DE3683342D1 (de) 1985-10-15 1986-10-02 Verfahren zur herstellung von tabletten von isosorbid-5-mononitrat mit verzoegerter abgabe und so erhaltene zusammensetzungen.
ES198686201705T ES2035819T3 (es) 1985-10-15 1986-10-02 Procedimiento para la preparacion de tabletas de isosorbido-5-moninitrato de liberacion sostenida y las formulaciones obtenidas.
EP86201705A EP0219161B1 (en) 1985-10-15 1986-10-02 Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained
AT86201705T ATE71290T1 (de) 1985-10-15 1986-10-02 Verfahren zur herstellung von tabletten von isosorbid-5-mononitrat mit verzoegerter abgabe und so erhaltene zusammensetzungen.
AU63831/86A AU591185B2 (en) 1985-10-15 1986-10-13 Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained
JP61241570A JPS62123114A (ja) 1985-10-15 1986-10-13 安定化されたイソソルビド−５−モノニトレ−ト錠剤及びその製造方法
US06/918,385 US4812316A (en) 1985-10-15 1986-10-14 Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained
ZA867768A ZA867768B (en) 1985-10-15 1986-10-14 Process for the preparation of stabilized isosorbide-5-mononitrate tablets,being also of sustained release,and formulation thus obtained
CA000520377A CA1285489C (en) 1985-10-15 1986-10-14 Process for the preparation of stabilized isosorbide- 5-mononitrate tablets, being also of sustained release, and formulations thus obtained
GR920400639T GR3004285T3 (it) 1985-10-15 1992-04-07
HK12295A HK12295A (en) 1985-10-15 1995-01-26 Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22493/85A IT1187750B (it) 1985-10-15 1985-10-15 Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute

Publications (2)

Publication Number Publication Date
IT8522493A0 true IT8522493A0 (it) 1985-10-15
IT1187750B IT1187750B (it) 1987-12-23

Family

ID=11197007

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22493/85A IT1187750B (it) 1985-10-15 1985-10-15 Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute

Country Status (12)

Country Link
US (1) US4812316A (it)
EP (1) EP0219161B1 (it)
JP (1) JPS62123114A (it)
AT (1) ATE71290T1 (it)
AU (1) AU591185B2 (it)
CA (1) CA1285489C (it)
DE (1) DE3683342D1 (it)
ES (1) ES2035819T3 (it)
GR (1) GR3004285T3 (it)
HK (1) HK12295A (it)
IT (1) IT1187750B (it)
ZA (1) ZA867768B (it)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64726B1 (en) * 1987-11-20 1995-08-23 Elan Corp Plc Pharmaceutical formulations for preventing drug tolerance
IT1237638B (it) * 1989-10-25 1993-06-12 Ghirardi Paolo E. Impiego dell'isosorbide 2-mononitrato per la preparazione di composi- zioni farmaceutiche atte al trattamento dell'angina pectoris
FR2666506A1 (fr) * 1990-09-07 1992-03-13 Pf Medicament Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation.
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE4313726A1 (de) * 1993-04-27 1994-11-03 Byk Nederland Bv Feste Darreichungsform
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
DE19515972A1 (de) * 1995-05-02 1996-11-07 Bayer Ag Arzneizubereitungen mit kontrollierter Freisetzung und Verfahren zu ihrer Herstellung
US5900425A (en) * 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
AU3861397A (en) * 1996-08-02 1998-02-25 Cal International Limited Controlled release tablet formulation of isosorbide-5-mononitrate
US5851555A (en) * 1997-08-15 1998-12-22 Fuisz Technologies Ltd. Controlled release dosage forms containing water soluble drugs
PE20011065A1 (es) 2000-02-01 2001-11-21 Procter & Gamble Proceso para fabricar bisfosfonatos geminales
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
JP4696210B2 (ja) * 2000-06-07 2011-06-08 トーアエイヨー株式会社 イソソルビド‐５‐モノニトレートを有効成分とする徐放性錠剤及びその製造方法
JP4840549B2 (ja) * 2000-11-20 2011-12-21 トーアエイヨー株式会社 安定な血管拡張剤及びその製造方法
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
AU2006340298B2 (en) * 2006-03-16 2012-10-04 Glycologic Limited Gastric raft composition comprising preferably processed starches for inducing satiety
CN111068644B (zh) * 2019-12-20 2023-01-03 中海油天津化工研究设计院有限公司 一种均四甲苯氧化制均酐催化剂及其制备方法
CN115487162B (zh) * 2022-10-13 2023-10-13 山东力诺制药有限公司 一种单硝酸异山梨酯缓释片的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2301664C3 (de) * 1973-01-13 1979-07-12 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral verabreichbares, Nitroglycerin enthaltendes Arzneimittel
US3972995A (en) * 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3325652A1 (de) * 1983-07-15 1985-01-24 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Feste, stabile isosorbid-5-mononitrat enthaltende arzneimittelzubereitungen und verfahren zu ihrer herstellung
JPS60181052A (ja) * 1984-02-29 1985-09-14 Tooa Eiyoo Kk 安定なイソソルビド硝酸エステル組成物及びその製造法

Also Published As

Publication number Publication date
CA1285489C (en) 1991-07-02
HK12295A (en) 1995-02-03
JPS62123114A (ja) 1987-06-04
JPH0524888B2 (it) 1993-04-09
AU591185B2 (en) 1989-11-30
ATE71290T1 (de) 1992-01-15
EP0219161B1 (en) 1992-01-08
EP0219161A2 (en) 1987-04-22
ZA867768B (en) 1987-06-24
IT1187750B (it) 1987-12-23
AU6383186A (en) 1987-04-16
GR3004285T3 (it) 1993-03-31
US4812316A (en) 1989-03-14
DE3683342D1 (de) 1992-02-20
EP0219161A3 (en) 1988-01-13
ES2035819T3 (es) 1993-05-01

Similar Documents

Publication Publication Date Title
IT8522493A0 (it) Ottenute. procedimento per la preparazione di compresse, anche a rilascio prolungato, di isosorbide-5-mononitrato stabilizzato e formulazioni cosi'
IT8522494A0 (it) Procedimento per la preparazione di formulazioni solide di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute.
DE68911473D1 (de) Arzneimittelformulierungen.
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
IT1209667B (it) Composizione effeverscente adattivita' analgesica.
FI860559A0 (fi) 11 -fenyl-gonaner, deras framstaellning och dessa innehaollande farmaceutiska preparat.
IT8820145A0 (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
IT8819100A0 (it) Formulazioni galeniche a cessione programmata.
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
DE3680137D1 (de) Pyridazinonderivate, deren herstellung und insektizide, akarizide, nematizide, fungizide zusammensetzungen.
IT8522668A0 (it) Procedimento per la preparazione di (2,2)-paraciclofani alogenati e miscele di (2,2)-paraciclofani alogenati ottenuti.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
DE3682960D1 (de) Pharmazeutische praeparate.
DE3576118D1 (de) Pharmazeutische praeparate.
ES551635A0 (es) Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides.
IT8722264A0 (it) Procedimento per la preparazione di compresse solubili e/o divisibili e compresse cosi' ottenute.
EP0213713A3 (en) 2-oxopyrrolidine pharmaceutical compounds, salts thereof, and the preparation thereof
IT8619206A0 (it) Procedimento per la preparazione di 4,4-dialchil-2-azetidinoni.
FI870732A (fi) Glycero-3(2)-fosfo-l-serinderivat och deras salter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
IT8622780A0 (it) "2-cloro-12-(-3-dimetilammino-2-metilpropil)-12h-dibenzo-/d,g//1,3,6/d iossazocine otticamente attive eprocedimento per la loro preparazione.
IT1230571B (it) Procedimento per la preparazione di formulazioni antiacido ad azione protratta e formulazioni cosi'ottenute.
DE3667915D1 (de) Pharmazeutische zusammensetzung.
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
MX9203583A (es) Composicion farmaceutica de liberacion prolongada a base de 9,10-dihidro-alcaloides.